Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating activities:
Net loss	$ (4,570,576)	$ (1,862,962)
Adjustments required to reconcile net loss to net cash used in operating activities:
Amortization	3,612	3,609
Stock-based compensation	660,582	677,988
Changes in operating assets and liabilities:
Accounts payable	(526,732)	(92,550)
Accrued interest	36,606	73,212
Unreimbursed expenses (accrued)	104,960	47,741
Related party payable
Net cash used in operating activities	(4,291,548)	(1,152,962)
Financing activities:
Net proceeds from initial public offering, follow-on offering, exercise of Green Shoe, and exercise of underwriter warrants	3,110,596	30,166,502
Repayment to related party/shareholder		(360,000)
Advance from related party/shareholder	(275,154)
Net cash provided by (used in) financing activities	2,835,442	29,806,502
Net increase (decrease) in cash	(1,456,106)	28,653,540
Cash, beginning of period	28,660,375	6,835
Cash, end of period	27,204,269	28,660,375
Non-cash investing and financing activities:
Common stock to settle related party payable
Conversion of preferred stock to common		2,023
Issuance of preferred stock due to antidilution		$ 42